Trauma and glucose metabolism disorders
Conditions
Interventions
trauma group vs control group:no
Sponsors
Shanghai Jiao Tong University Affiliated Sixth People's Hospital,Shanghai, China
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: With multiple trauma patients as the research object, this study ISS score to selected patients with ISS > 16 points for the experimental group, choose the school age, body mass index (BMI) that match the healthy check-up crowd as the control group.;Inclusion criteria: With multiple trauma patients as the research object, this study ISS score to selected patients with ISS > 16 points for the experimental group, choose the school age, body mass index (BMI) that match the healthy check-up crowd as the control group.;Inclusion criteria: With multiple trauma patients as the research object, this study ISS score to selected patients with ISS > 16 points for the experimental group, choose the school age, body mass index (BMI) that match the healthy check-up crowd as the control group.;Inclusion criteria: With multiple trauma patients as the research object, this study ISS score to selected patients with ISS > 16 points for the experimental group, choose the school age, body mass index (BMI) that match the healthy check-up crowd as the control group.;Inclusion criteria: With multiple trauma patients as the research object, this study ISS score to selected patients with ISS > 16 points for the experimental group, choose the school age, body mass index (BMI) that match the healthy check-up crowd as the control group.
Exclusion criteria
Exclusion criteria: History of high blood pressure, diabetes, coronary heart disease, severe liver function damage, severe renal impairment, a history of anemia of chronic disease, malignant tumor, hyperparathyroidism or thyroid dysfunction, pregnancy, a history of fractures within 1 year, recent known to affect bone metabolism of drugs, such as vitamin D, calcitonin, estrogen, etc;Exclusion criteria: History of high blood pressure, diabetes, coronary heart disease, severe liver function damage, severe renal impairment, a history of anemia of chronic disease, malignant tumor, hyperparathyroidism or thyroid dysfunction, pregnancy, a history of fractures within 1 year, recent known to affect bone metabolism of drugs, such as vitamin D, calcitonin, estrogen, etc;Exclusion criteria: History of high blood pressure, diabetes, coronary heart disease, severe liver function damage, severe renal impairment, a history of anemia of chronic disease, malignant tumor, hyperparathyroidism or thyroid dysfunction, pregnancy, a history of fractures within 1 year, recent known to affect bone metabolism of drugs, such as vitamin D, calcitonin, estrogen, etc;Exclusion criteria: History of high blood pressure, diabetes, coronary heart disease, severe liver function damage, severe renal impairment, a history of anemia of chronic disease, malignant tumor, hyperparathyroidism or thyroid dysfunction, pregnancy, a history of fractures within 1 year, recent known to affect bone metabolism of drugs, such as vitamin D, calcitonin, estrogen, etc;Exclusion criteria: History of high blood pressure, diabetes, coronary heart disease, severe liver function damage, severe renal impairment, a history of anemia of chronic disease, malignant tumor, hyperparathyroidism or thyroid dysfunction, pregnancy, a history of fractures within 1 year, recent known to affect bone metabolism of drugs, such as vitamin D, calcitonin, estrogen, etc
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Osteocalcin, blood sugar, insulin concentration, c-peptide; | — |
Countries
China
Contacts
Public ContactYanping Yang;Yanping Yang;Yanping Yang;Yanping Yang;Yanping Yang ;;;;
;;;;
Outcome results
None listed